Researchers at UT Southwestern Medical Center have grown-up what they believe to be the first clinical form of a new imaging manner to diagnose brain tumors. The unique test could preclude the need for surgery in clients whose tumors are located in areas of the brain too dangerous to biopsy. This new captivating concord spectroscopy (MRS) modus operandi provides a determinative insight of cancer based on imaging of a protein customer's broker with a mutated gene found in 80 percent of low- and intermediate-grade gliomas. potentiality of the mutation also means a better prognosis...

More: - The rest...